Literature DB >> 27053540

Chryseobacterium indologenes: an emerging infection in the USA.

Ridhwi Mukerji1, Radhika Kakarala1, Susan Jane Smith1, Halina G Kusz1.   

Abstract

Nursing home-associated infections and antibiotic resistant pathogens constitute common and serious problems in the geriatric population.Chryseobacterium indologenes, a non-motile Gram-negative rod, though widely distributed in nature, is an uncommon human pathogen. Typically thought of as an organism of low virulence, it may cause serious infections, particularly among the immunocompromised. The majority of reported cases are nosocomial, often associated with immunosuppression or indwelling catheters. It has been reported as the causative agent in bacteraemia, peritonitis, pneumonia, empyema, pyelonephritis, cystitis, meningitis and central venous catheter-associated infections. We report a rare case of C. indologenesinfection affecting a nursing home resident in the USA and we provide a review of similar cases. This report emphasises the importance of individualised treatment and promotes awareness about this organism as one of several emerging pathogens in immunocompromised adults and in the frail elderly who are often nursing home residents, in the Western Hemisphere. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27053540      PMCID: PMC4840731          DOI: 10.1136/bcr-2016-214486

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  32 in total

1.  Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device.

Authors:  E Nulens; B Bussels; A Bols; B Gordts; H W Van Landuyt
Journal:  Clin Microbiol Infect       Date:  2001-07       Impact factor: 8.067

2.  Identification, epidemiological relatedness, and biofilm formation of clinical Chryseobacterium indologenes isolates from central Taiwan.

Authors:  Yi-Cheng Chang; Hsueh-Hsia Lo; Hsiu-Ying Hsieh; Shan-Min Chang
Journal:  J Microbiol Immunol Infect       Date:  2014-05-22       Impact factor: 4.399

3.  Flavobacterium indologenes bacteremia: clinical and microbiological characteristics.

Authors:  P R Hsueh; T R Hsiue; J J Wu; L J Teng; S W Ho; W C Hsieh; K T Luh
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

4.  Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient.

Authors:  Megan R Monteen; Supriya Ponnapula; G Christopher Wood; Martin A Croce; Joseph M Swanson; Bradley A Boucher; Timothy C Fabian
Journal:  Ann Pharmacother       Date:  2013-10-22       Impact factor: 3.154

5.  Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.

Authors:  S L Fraser; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

6.  Chryseobacterium indologenes peritonitis in peritoneal dialysis.

Authors:  Mehdi Afshar; Ehsan Nobakht; Susie Q Lew
Journal:  BMJ Case Rep       Date:  2013-05-24

7.  IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.

Authors:  Boukaré Zeba; Filomena De Luca; Alain Dubus; Michael Delmarcelle; Jacques Simporé; Odile G Nacoulma; Gian Maria Rossolini; Jean-Marie Frère; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

8.  Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

Authors:  Jeffrey T Kirby; Helio S Sader; Timothy R Walsh; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Identification and susceptibility to multipurpose disinfectant solutions of bacteria isolated from contact lens storage cases of patients with corneal infiltrative events.

Authors:  Simon Kilvington; Joseph Shovlin; Marina Nikolic
Journal:  Cont Lens Anterior Eye       Date:  2013-03-01       Impact factor: 3.077

10.  Chryseobacterium indologenes in a woman with metastatic breast cancer in the United States of America: a case report.

Authors:  Seema Yasmin; Greg Garcia; Tammy Sylvester; Rebecca Sunenshine
Journal:  J Med Case Rep       Date:  2013-07-26
View more
  10 in total

1.  Chryseobacterium indologenes, an Emerging Bacteria: A Case Report and Review of Literature.

Authors:  Dora E Izaguirre-Anariba; Vel Sivapalan
Journal:  Cureus       Date:  2020-01-21

2.  Survey on Carbapenem-Resistant Bacteria in Pigs at Slaughter and Comparison with Human Clinical Isolates in Italy.

Authors:  Silvia Bonardi; Clotilde Silvia Cabassi; Gerardo Manfreda; Antonio Parisi; Enrico Fiaccadori; Alice Sabatino; Sandro Cavirani; Cristina Bacci; Martina Rega; Costanza Spadini; Mattia Iannarelli; Cecilia Crippa; Ferdinando Ruocco; Frédérique Pasquali
Journal:  Antibiotics (Basel)       Date:  2022-06-07

3.  Chryseobacterium Indologenes Pneumonitis in an Infant: A Case Report.

Authors:  Parijat Das; Santosh Karade; Kanwaljit Kaur; Ravi Ramamurthy; Praveer Ranjan
Journal:  J Clin Diagn Res       Date:  2017-06-01

4.  Whole genome sequencing uncovers a novel IND-16 metallo-β-lactamase from an extensively drug-resistant Chryseobacterium indologenes strain J31.

Authors:  Shaoqiang Wu; Beiwen Zheng; Tingting Wang; Xiawei Jiang; Chunyan Feng; Ang Li; Huihui Dong
Journal:  Gut Pathog       Date:  2016-10-21       Impact factor: 4.181

5.  Planarian regeneration in space: Persistent anatomical, behavioral, and bacteriological changes induced by space travel.

Authors:  Junji Morokuma; Fallon Durant; Katherine B Williams; Joshua M Finkelstein; Douglas J Blackiston; Twyman Clements; David W Reed; Michael Roberts; Mahendra Jain; Kris Kimel; Sunia A Trauger; Benjamin E Wolfe; Michael Levin
Journal:  Regeneration (Oxf)       Date:  2017-06-13

6.  Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial.

Authors:  Rea Bingula; Edith Filaire; Ioana Molnar; Eve Delmas; Jean-Yves Berthon; Marie-Paule Vasson; Annick Bernalier-Donadille; Marc Filaire
Journal:  Respir Res       Date:  2020-05-25

7.  COVID-19 Associated Bacteremia with Chryseobacterium indologenes Co-Harboring bla IND-2, bla CIA and bla CcrA.

Authors:  Ting-Kuang Yeh; Zong-Hao Li; Yao-Ting Huang; Po-Yu Liu
Journal:  Infect Drug Resist       Date:  2022-01-20       Impact factor: 4.003

8.  Chryseobacterium Indologenes Sepsis and Acute Renal Failure Secondary to Abdominal Compartment Syndrome in a Confirmed COVID-19 Patient.

Authors:  Alejandro José Quiroz Alfaro; Iván Javier Rodríguez Acosta; Mayumi Tanaka Takegami; Liliana Michelle Bracho Maya; Roberto Eduardo Quiroz Simanca
Journal:  Case Rep Crit Care       Date:  2022-04-14

9.  Whole genome sequencing of the multidrug-resistant Chryseobacterium indologenes isolated from a patient in Brazil.

Authors:  Marcelo Silva Folhas Damas; Roumayne Lopes Ferreira; Emeline Boni Campanini; Gabriela Guerrera Soares; Leslie Camelo Campos; Pedro Mendes Laprega; Andrea Soares da Costa; Caio César de Melo Freire; André Pitondo-Silva; Louise Teixeira Cerdeira; Anderson Ferreira da Cunha; Maria-Cristina da Silva Pranchevicius
Journal:  Front Med (Lausanne)       Date:  2022-07-28

10.  Chryseobacterium indologenes Ventilator-Associated Pneumonia in an Elderly Patient: A Case Report.

Authors:  Mahdi M Fadlallah; Darine M Kharroubi; Zeinab Zeineddine; Sarah M Salman
Journal:  Cureus       Date:  2022-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.